Aspira Women's Health Inc. (AWH)
NASDAQ: AWH · Real-Time Price · USD
0.157
-0.019 (-10.57%)
Mar 12, 2025, 10:23 AM EST - Market open
Aspira Women's Health Revenue
Aspira Women's Health had revenue of $2.26M in the quarter ending September 30, 2024, with 1.80% growth. This brings the company's revenue in the last twelve months to $8.96M, down -2.33% year-over-year. In the year 2023, Aspira Women's Health had annual revenue of $9.15M with 11.85% growth.
Revenue (ttm)
$8.96M
Revenue Growth
-2.33%
P/S Ratio
0.25
Revenue / Employee
$140,047
Employees
64
Market Cap
2.61M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 9.15M | 970.00K | 11.85% |
Dec 31, 2022 | 8.18M | 1.37M | 20.14% |
Dec 31, 2021 | 6.81M | 2.16M | 46.46% |
Dec 31, 2020 | 4.65M | 113.00K | 2.49% |
Dec 31, 2019 | 4.54M | 1.49M | 48.64% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
AWH News
- 1 day ago - Aspira Women's Health Announces Closing of $1.37 Million Private Placement of Convertible Notes - Accesswire
- 26 days ago - Aspira Women's Health Submits Request for Withdrawal of Form S-1 Registration Statement - Accesswire
- 4 weeks ago - Aspira Women's Health Announces Appointment of Ellen Beausang to the Board of Directors - Accesswire
- 2 months ago - Aspira Women's Health Announces the Appointment of Mike Buhle as SVP of Commercial Operations - Accesswire
- 3 months ago - Aspira Women's Health Announces Appointment of Dr. Sandra Milligan as Interim CEO - GlobeNewsWire
- 3 months ago - Aspira Women's Health Successfully Reaches the First Milestone of the ARPA-H $10 Million Award - GlobeNewsWire
- 4 months ago - Aspira Women's Health Inc. (AWH) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Aspira Women's Health to Announce Third Quarter Earnings Results and Host a Conference Call on Thursday, November 14, 2024 - GlobeNewsWire